ONTEX Ontex Group N.V.

Transparency Declaration Notification

Transparency Declaration Notification

Regulated information

In accordance with the requirements of Article 14 of the Belgian Law of May 2, 2007 on the disclosure of significant shareholdings in listed companies, Ontex Group NV (“Ontex”) discloses the notifications of significant shareholdings by the Goldman Sachs Group, Inc., that it has received on August 13 and 14, 2025.

On August 7, 2025, the Goldman Sachs Group, Inc., detained 2,559,642 Ontex voting rights or equivalent financial instruments, representing 3.11% of voting rights, and thereby crossed upward the threshold of 3.0%.

On August 8, 2025, the Goldman Sachs Group, Inc., detained 2,384,086 Ontex voting rights or equivalent financial instruments, representing 2.90% of voting rights, and thereby crossed downward the threshold of 3.0%.

Enquiries

  • Investors:      Geoffroy Raskin                    
  • Media:            Catherine Weyne                 

About Ontex

Ontex is a leading international developer and producer of baby care, feminine care and adult care products, for retailer and healthcare brands across Europe and North America. The group employs about 5,500 people with plants and offices in 12 countries (excl. discontinued operations), and its innovative products are distributed in around 100 countries. is headquartered in Aalst, Belgium, and is listed on , where it is a constituent of the index. To keep up with the latest news, visit or follow Ontex on .

Attachment



EN
18/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ontex Group N.V.

 PRESS RELEASE

Transparency Declaration Notification

Transparency Declaration Notification Regulated information In accordance with the requirements of Article 14 of the Belgian Law of May 2, 2007 on the disclosure of significant shareholdings in listed companies, Ontex Group NV (“Ontex”) discloses the notifications of significant shareholdings by the Goldman Sachs Group, Inc., that it has received on August 13 and 14, 2025. On August 7, 2025, the Goldman Sachs Group, Inc., detained 2,559,642 Ontex voting rights or equivalent financial instruments, representing 3.11% of voting rights, and thereby crossed upward the threshold of 3.0%. On Au...

 PRESS RELEASE

Kennisgeving transparantieverklaring

Kennisgeving transparantieverklaring Geregelementeerde informatie In overeenstemming met de vereisten van artikel 14 van de Belgische wet van 2 mei 2007 over de openbaarmaking van belangrijke deelnemingen in emittenten, maakt Ontex Group NV (“Ontex”) de verklaringen van belangrijke deelnemingen door Goldman Sachs Group, Inc., bekend die op 13 en 14 augustus 2025 werden ontvangen. Op 7 augustus 2025 bezat Goldman Sachs Group, Inc., 2.559.642 stemrechten of equivalente financiële instrumenten van Ontex, wat 3,11% van de stemrechten voorstelt. Zij hebben daarmee de drempel van 3,0% opwaarts ...

Carole Braudeau
  • Carole Braudeau
AXA AXA
CEC CECONOMY AG ... (+13)

Credit Morning 08/01/2025

S&P lowers outlook to negative vs. stable on ELO's 'BB-' rating|ZF H1 25 results: Better than one could have feared… but some water into the wine|Emeria announces the sale of Assurimo|Viridien: Profitability improvement, good FCF generation, and guidance confirmed|

Carole Braudeau
  • Carole Braudeau
AXA AXA
CEC CECONOMY AG ... (+13)

Morning Crédit 01/08/2025

ELO : S&P abaisse la perspective de stable à négative sur le rating BB-|ZF H1 25 results: Better than one could have feared… but some water into the wine|Emeria annonce la cession d’Assurimo|Viridien: Profitability improvement, good FCF generation, and guidance confirmed|

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

AB InBev: 2Q25 results. Air France-KLM: Nice beat, let's see how FY25 finishes. AMG: Uptrend continues in 2Q25 with 23% EBITDA beat and guidance up to +US$200m. Aperam: Slight 2Q25 EBITDA beat, 3Q25 seen down QoQ. Arcadis: EBITA margin held up well in 2Q25, order intake mixed. Ayvens: 2Q25 results. Azelis: Soft but largely in-line 2Q25 with EMEA offsetting weaker APAC. Bekaert: 1H25 miss and lowered outlook to result in c.5% consensus downside. Corbion: Taking it to the wire. dsm...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch